• FXR Phase Separation Clusters Viral Organelles

  2026-09-01

  The reference study identifies fragile X–related proteins as host factors that organize coronavirus double-membrane vesicles through liquid–liquid phase separation. Its findings connect condensate biology with replication-organelle architecture and suggest experimental strategies for separating organelle clustering, viral RNA synthesis, and translation in mechanistic antiviral studies.

• Rapid Purification of Recombinant Annexin V

  2026-09-01

  Burger and colleagues developed a short purification workflow for recombinant annexin V that combines gentle osmotic opening of Escherichia coli with reversible calcium-dependent liposome binding and final ion-exchange chromatography. The approach produced protein sufficiently pure for crystallography, electron microscopy, spectroscopy, and single-channel measurements, while addressing co-purification problems associated with harsher cell-disruption methods.

• Perifosine Workflows for Akt and Apoptosis Research

  2026-08-31

  Build reproducible Perifosine and KRX-0401 experiments around Akt target engagement, apoptosis, and radiation response. This workflow also shows how to use Akt inhibition as a mechanistic perturbation when studying OM-MSC-mediated protection from cerebral ischemia/reperfusion injury.

• Cepharanthine Inhibits Endometriosis Across Models

  2026-08-31

  A 2026 study evaluated Cepharanthine in endometriotic stromal cells, patient-derived eutopic endometrial organoids, and a murine peritoneal model. The results connect reduced lesion growth with G0/G1 arrest, DNA damage, impaired repair, and mitochondrial apoptosis, while also illustrating how organoids can strengthen preclinical endometriosis research.

• Amikacin as a Transmission-Phenotype Probe

  2026-08-30

  Amikacin and BAY416651 can do more than produce a susceptibility endpoint. This article presents a phenotype-to-transmission framework for interpreting aminoglycoside activity alongside carbapenemase location, plasmid mobility, and clonal dissemination.

• Ampicillin Sodium: From MIC to Mechanism

  2026-08-29

  Ampicillin sodium is a β-lactam antibiotic whose value extends beyond routine growth inhibition. This evidence-led guide connects transpeptidase biology, MIC interpretation, resistance research, and infection-model translation into a more rigorous assay strategy.

• Lactobacillus acidophilus and UDCA in Ulcerative Colitis

  2026-08-28

  Deng et al. show that Lactobacillus acidophilus improves experimental ulcerative colitis partly through microbiota-dependent elevation of ursodeoxycholic acid. The study links this metabolite to coordinated Treg promotion and suppression of M1 macrophage polarization through the RapGap/PI3K-AKT/NF-κB axis, providing a mechanistic framework for probiotic–metabolite therapy.

• Geneticin, G-418 Sulfate: Selection to Translation

  2026-08-28

  Geneticin, also known as G418 Sulfate, is more than a routine selection reagent. Its ribosomal mechanism, resistance-gene logic, and emerging antiviral use provide a framework for building more interpretable cell models and translational workflows.

• Amikacin Sulfate: Intracellular Assay Strategy

  2026-08-27

  Amikacin Sulfate supports rigorous investigation of intracellular non-tuberculous mycobacterial infection. This article presents an assay-design framework inspired by functional metagenomics and clarifies how uptake, bactericidal activity, delivery, and genetic controls should be interpreted together.

• Biotin Azide for Mechanism-Driven Click Assays

  2026-08-26

  Biotin Azide enables selective capture of terminal-alkyne biomolecules through CuAAC, linking bio-orthogonal labeling to sensitive streptavidin-based analysis. This guide shows how Biotin-azide can support assay designs inspired by the Frizzled5–cholesterol–Wnt mechanism while preserving critical controls and biological interpretation.

• NVP-BGJ398 Phosphate: From Signal to Phenotype

  2026-08-26

  NVP-BGJ398 phosphate is a potent FGFR1–3 inhibitor that connects receptor-level pharmacology with cancer and skeletal disease phenotypes. This article explains how to design translational assays around FGFR3 signaling, genetic validation, and tissue-level readouts.

• Griseofulvin: Microtubule Inhibitor for Fungal Research

  2026-08-25

  Griseofulvin is a microtubule associated inhibitor used to study fungal cell mitosis inhibition and microtubule disruption mechanism. The B3680 research product is a solid, approximately 98% pure compound with documented DMSO solubility and recommended storage at -20°C.

• Acifran for Lipid Metabolism Research

  2026-08-25

  Acifran enables controlled HM74A/GPR109A and GPR109B agonism for receptor signaling, cAMP, and lipid-regulation workflows. This guide translates recent cryo-EM findings into practical assay design, comparative receptor testing, and troubleshooting strategies.

• Ampicillin Sodium: From Mechanism to Translation

  2026-08-24

  Ampicillin sodium is more than a routine selection antibiotic: it is a mechanistically defined perturbation for connecting transpeptidase inhibition with cellular lysis, infection-model behavior, and reproducible recombinant workflows. This thought-leadership article outlines how translational researchers can use its reported potency, solution properties, and quality controls without mistaking product specifications for universal biological thresholds. It also shows how evidence from recombinant annexin V purification can inform workflow discipline while clarifying the limits of cross-domain interpretation.

• LG 101506: RXR Modulator Workflow

  2026-08-24

  Build controlled RXR signaling pathway research around LG 101506 with formulation-aware dosing, orthogonal readouts, and clear decision points. The workflow also shows how to examine RXR biology alongside the RBMS1–PD-L1 axis in triple-negative breast cancer without treating an untested connection as established biology.

8562 records 1/571 page Next 12345 下5页 Last page